Clearstead Advisors’s Clorox CLX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $2.23M | Buy |
23,327
+18,443
| +378% | +$1.77M | 0.02% | 365 |
|
|
2026
Q1 | $506K | Sell |
4,884
-1,719
| -26% | -$195K | ﹤0.01% | 705 |
|
|
2025
Q4 | $666K | Buy |
6,603
+248
| +4% | +$26.9K | 0.01% | 579 |
|
|
2025
Q3 | $784K | Sell |
6,355
-219
| -3% | -$27.2K | 0.01% | 514 |
|
|
2025
Q2 | $789K | Sell |
6,574
-606
| -8% | -$80.8K | 0.01% | 498 |
|
|
2025
Q1 | $1.06M | Buy |
7,180
+566
| +9% | +$86.4K | 0.02% | 397 |
|
|
2024
Q4 | $1.07M | Sell |
6,614
-139
| -2% | -$22.7K | 0.02% | 400 |
|
|
2024
Q3 | $1.1M | Sell |
6,753
-1,629
| -19% | -$241K | 0.02% | 403 |
|
|
2024
Q2 | $1.14M | Buy |
8,382
+7,455
| +804% | +$1.04M | 0.02% | 366 |
|
|
2024
Q1 | $131K | Buy |
927
+7
| +0.8% | +$1.04K | 0.01% | 550 |
|
|
2023
Q4 | $131K | Sell |
920
-51
| -5% | -$6.8K | 0.01% | 532 |
|
|
2023
Q3 | $127K | Sell |
971
-1
| -0.1% | -$152 | 0.01% | 505 |
|
|
2023
Q2 | $155K | Sell |
972
-27
| -3% | -$4.36K | 0.01% | 474 |
|
|
2023
Q1 | $158K | Buy |
999
+1
| +0.1% | +$150 | 0.01% | 428 |
|
|
2022
Q4 | $140K | Buy |
998
+31
| +3% | +$4.4K | 0.01% | 431 |
|
|
2022
Q3 | $124K | Sell |
967
-66
| -6% | -$9.52K | 0.01% | 430 |
|
|
2022
Q2 | $146K | Hold |
1,033
| – | – | 0.01% | 425 |
|
|
2022
Q1 | $144K | Buy |
1,033
+21
| +2% | +$3.22K | 0.01% | 471 |
|
|
2021
Q4 | $176K | Sell |
1,012
-33
| -3% | -$5.5K | 0.01% | 417 |
|
|
2021
Q3 | $173K | Sell |
1,045
-3
| -0.3% | -$517 | 0.01% | 392 |
|
|
2021
Q2 | $189K | Sell |
1,048
-10
| -0.9% | -$1.82K | 0.01% | 352 |
|
|
2021
Q1 | $204K | Sell |
1,058
-613
| -37% | -$118K | 0.02% | 335 |
|
|
2020
Q4 | $337K | Buy |
1,671
+176
| +12% | +$36.4K | 0.03% | 247 |
|
|
2020
Q3 | $314K | Buy |
1,495
+6
| +0.4% | +$1.34K | 0.03% | 227 |
|
|
2020
Q2 | $327K | Hold |
1,489
| – | – | 0.04% | 217 |
|
|
2020
Q1 | $258K | Hold |
1,489
| – | – | 0.04% | 211 |
|
|
2019
Q4 | $229K | Hold |
1,489
| – | – | 0.03% | 259 |
|
|
2019
Q3 | $226K | Sell |
1,489
-115
| -7% | -$18.2K | 0.03% | 242 |
|
|
2019
Q2 | $246K | Buy |
+1,604
| New | +$245K | 0.03% | 241 |
|
|
2018
Q2 | – | Sell |
-1,510
| Closed | -$201K | – | 224 |
|
|
2018
Q1 | $201K | Sell |
1,510
-465
| -24% | -$62.5K | 0.03% | 217 |
|
|
2017
Q4 | $294K | Sell |
1,975
-96
| -5% | -$13.1K | 0.04% | 182 |
|
|
2017
Q3 | $273K | Sell |
2,071
-28
| -1% | -$3.76K | 0.04% | 205 |
|
|
2017
Q2 | $280K | Buy |
2,099
+28
| +1% | +$3.78K | 0.04% | 194 |
|
|
2017
Q1 | $279K | Hold |
2,071
| – | – | 0.04% | 185 |
|
|
2016
Q4 | $249K | Buy |
+2,071
| New | +$244K | 0.04% | 184 |
|
Other funds holding CLX
Clearstead Advisors's CLX Position: Q2 2026 in Review
Clearstead Advisors increased its Clorox (CLX) stake by 378% in Q2 2026, buying an estimated $1.77M and bringing the position to 23,327 shares worth $2.23M. The position accounts for 0.02% of the portfolio, ranked #365.
Clearstead Advisors first reported a position in CLX in Q4 2016 and has held it in 35 quarters since. 1,041 funds tracked by Wall St. Rank hold CLX as of Q2 2026.
- Clearstead Advisors held 23,327 shares of Clorox worth $2.23M as of Q2 2026.
- Clearstead Advisors bought 18,443 Clorox shares in Q2 2026, an estimated $1.77M.
- Clorox made up 0.02% of Clearstead Advisors's portfolio in Q2 2026, its #365 holding.
- Clearstead Advisors first reported a position in Clorox in Q4 2016 and has held it in 35 quarters since.
- 1,041 funds tracked by Wall St. Rank held Clorox as of Q2 2026.
Based on Clearstead Advisors's 13F filing for Q2 2026, filed 6 Aug 2026.